In his commentary, this author summarizes the findings of the four main papers on obesity in this Lancet issue. He calls the series “highly relevant to clinicians and policy makers. It renews attention to the obesity epidemic and the cost and consequences of inaction.”
Dietz finds optimism in the fact that heightened awareness of adverse effects might have contributed to a reduced rate of increase in obesity in the United States and United Kingdom. “We could be at a turning point, but we have not yet turned the corner. The challenge posed by this series is how to implement the strategies necessary to reverse these trends.”
He cites a number of U.S. efforts that have begun to address obesity:
“Whether these and other initiatives in the USA will be transformative remains to be seen. Nonetheless, the struggle to prevent and control obesity has been intensified,” he concludes.